Kova review
Kova sets out the entire ladder in ordinary sentences — "1-month plan: $249 for your first month, then renews at $299/month thereafter. 3-month plan: $179/month, or $537 upfront" — and every multiplication in it is exact. That sounds like a low bar until you have read a few sites whose per-month figures turn out to be averages hiding a one-off discount. Kova's are the real thing, and it offers the term plans monthly as well as up front. The figure to plan around is the renewal: $299 for semaglutide, $399 for tirzepatide.
then $299/mo ongoing
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Kova at a glance
- Semaglutide
- $299/mo after the first month on the one-month plan
- Tirzepatide
- $399/mo after the first month on the one-month plan
- Coverage
- Not published on the site
- Brand-name
- Compounded only
How we scored Kova
Each score comes out of Kova's published pricing, disclosures and oversight, and the six combine into the 48/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Cost is unpredictable, premium, or hides behind a plan commitment.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- trykova.com/pricing
Read from Kova's own pricing page in August 2026, where the whole ladder is written out in sentences. Compounded semaglutide is $249 for a first month and then renews at $299; committing to three, six or twelve months brings it to $179, $149 or $129 a month. Tirzepatide is $299 then $399, or $249, $229 and $199 on the term plans. Every upfront total is exactly the monthly rate times the term, so these are true per-month prices rather than averages, and Kova says you may pay monthly or up front. It publishes no list of states and names no compounding pharmacy.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $249 → $299 | One-month plan"1-month plan: $249 for your first month, then renews at $299/month thereafter." |
| Compounded semaglutide | $179 | Three-month plan"$179/month, or $537 upfront" — and $179 × 3 is exactly $537. |
| Compounded semaglutide | $149 | Six-month plan"$149/month, or $894 upfront." |
| Compounded semaglutide | $129 | Twelve-month plan"$129/month, or $1,548 upfront." |
| Compounded tirzepatide | $299 → $399 | One-month plan"1-month plan: $299 for your first month, then renews at $399." |
| Compounded tirzepatide | $249 | Three-month plan"$249/month, or $747 upfront." |
| Compounded tirzepatide | $229 | Six-month plan"$229/month, or $1,374 upfront." |
| Compounded tirzepatide | $199 | Twelve-month plan"$199/month, or $2,388 upfront." |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Kova's public disclosures at last review and change often; confirm the current number on Kova's own site.
What we like
- Sets out the full ladder in plain sentences, renewal rate included — "$249 for your first month, then renews at $299/month thereafter"
- Its per-month figures are genuine per-month figures: every upfront total is exactly the monthly rate times the term
- The longer plans can be paid monthly or in one payment, so the discount does not require a lump sum
- Four term lengths for each molecule, making the trade between commitment and cost visible at once
- Names its operating entity and a street address
The caveats
- The low advertised prices need a term commitment — $129/mo for semaglutide means signing up for twelve months
- Month to month, the price rises after the first month: $249 to $299 for semaglutide, $299 to $399 for tirzepatide
- No list of states served
- No compounding pharmacy is named
- Pricing is published per plan rather than per dose, so nothing is said about what happens as you titrate up
Kova for mothers: our verdict
Kova sets out the entire ladder in ordinary sentences — "1-month plan: $249 for your first month, then renews at $299/month thereafter. 3-month plan: $179/month, or $537 upfront" — and every multiplication in it is exact. That sounds like a low bar until you have read a few sites whose per-month figures turn out to be averages hiding a one-off discount. Kova's are the real thing, and it offers the term plans monthly as well as up front. The figure to plan around is the renewal: $299 for semaglutide, $399 for tirzepatide. The advertised entry is $249, but the standing rate settles near $299/month — so read the headline as a starting offer, not the real monthly cost.
We weigh Kova the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Kova actually costs
- Compounded semaglutide — One-month plan: $249 to start, then $299/mo
- Compounded semaglutide — Three-month plan: $179/mo
- Compounded semaglutide — Six-month plan: $149/mo
- Compounded semaglutide — Twelve-month plan: $129/mo
- Compounded tirzepatide — One-month plan: $299 to start, then $399/mo
- Compounded tirzepatide — Three-month plan: $249/mo
For context, the typical ongoing price across our roster is around $179/month, so Kova sits at the premium end.
The medications Kova prescribes
Kova prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Kova fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Kova's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Kova is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone weighing commitment against price who wants the arithmetic already done, and done correctly.
Alternatives to Kova
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Kova
Head-to-head & alternatives
Kova, answered
- How much does Kova cost?
- When we last checked, the cheapest ongoing compounded price at Kova was around $299 a month: $299/mo after the first month on the one-month plan for semaglutide and $399/mo after the first month on the one-month plan for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is Kova safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Kova as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Kova offer both semaglutide and tirzepatide?
- Yes — Kova offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Kova rank for mothers?
- Kova takes 48/100 in our Editors' Rating, placing it #203. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Kova's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.